Bod Science raises $1.9m to ease pressure on R&D costs by Steve Jones August 3, 2023August 3, 2023 Bod Science confirmed this morning it has received firm commitments to raise A$1.9 million in a […]
Bod Science clears stability hurdle for Aqua Phase deal but PK study delayed by Steve Jones March 7, 2023April 30, 2024
Company news: Avecho; Levin Health; Cannatrek; Releaf Group; Bod Science by Martin Lane and Steve Jones December 22, 2022April 29, 2024
Bod changes name to reflect focus on drug development and innovation by Steve Jones December 14, 2022April 29, 2024
Bod strikes CBD over-the-counter deal with pharma firm Arrotex by Steve Jones December 2, 2022April 29, 2024
